Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2152-2014Class II

VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific...

bioMerieux, Inc. / initiated 2013-10-14 / Terminated / root cause: packaging

BioMerieux SA began a recall of VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific antigen levels in human serum or plasma on . FDA classified it as Class II and gives the reason as "Product is not approved or authorized for distribution in the US". As of , the recall status on record is Terminated, and MDM tags the root cause as packaging.

Recall record

Recall number
Z-2152-2014
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
bioMerieux, Inc.
Product
VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific antigen levels in human serum or plasma.
Product code
MTF Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
Reason for recall
Product is not approved or authorized for distribution in the US.
Root cause tag
packaging
FDA root cause
Packaging process control
Action
A letter was issued on October 14, 2013 to consignees requesting the consignee to check their stock and destroy all kits of the VIDAS TPSA ref. 30428. The letter also requested that the consignee notify their accounts of the recall. An acknowledgment form was also included with the letter which is to be returned to BioMerieux.
Quantity in commerce
1902
Distribution
FL, LA, MI, MS, NV, OH, OK, TN, TX
Product codes and lots
Lot 1001904130

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2152-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2152-2014Class IITerminatedVoluntary: Firm initiated